omeprazole has been researched along with Abnormalities, Multiple in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the magnitude of possible fetal risks involved in maternal use of omeprazole during pregnancy." | 7.71 | Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. ( Källén, BA, 2001) |
| "To evaluate the magnitude of possible fetal risks involved in maternal use of omeprazole during pregnancy." | 3.71 | Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. ( Källén, BA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Källén, BA | 1 |
1 other study available for omeprazole and Abnormalities, Multiple
| Article | Year |
|---|---|
Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Anti-Ulcer Agents; Apgar Score; Birth W | 2001 |